Equity Capital Markets

Company · CIK 1662579

C4 Therapeutics, Inc.

CIK1662579 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedCCCC (Nasdaq)
First annual or quarterly report2020-11-12

Offerings

6 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-291696
ShelfEffective
 2025-11-212025-12-103
333-282933
ShelfEffective
 2024-10-312025-10-164
333-282934
ShelfEffective
 2024-10-312024-11-132
333-260972
ShelfEffective
 2021-11-102023-05-032
333-257067
Registered companyFinal prospectus
 2021-06-142021-06-213
333-248719
IPOFinal prospectus
 2020-09-102020-10-024

Filings

20
FiledFilingRegistrationAccession
2025-12-10EFFECTDeclared effective 333-2916969999999995-25-003638
2025-12-10424B5Shelf takedown 333-2916960001193125-25-314449
2025-11-21S-3Shelf registered 333-2916960001628280-25-053575
2025-10-16424B5Shelf takedown 333-2829330001193125-25-241586
2024-11-15424B5Shelf takedown 333-2829330001628280-24-048088
2024-11-13EFFECTDeclared effective 333-2829349999999995-24-003480
2024-11-13EFFECTDeclared effective 333-2829339999999995-24-003479
2024-10-31S-3Shelf registered 333-2829340001628280-24-044613
2024-10-31S-3Shelf registered 333-2829330001628280-24-044612
2023-05-03EFFECTDeclared effective 333-2609729999999995-23-001249
2021-11-10S-3ASRShelf registered 333-2609720001193125-21-326210
2021-06-21424B4Final prospectus 333-2570670001193125-21-194217
2021-06-16EFFECTDeclared effective 333-2570679999999995-21-002375
2021-06-14S-1Registration filed 333-2570670001193125-21-190020
2021-05-19DRSDraft made public 377-049050000950123-21-007184
2020-10-02424B4Final prospectus 333-2487190001193125-20-262629
2020-10-01EFFECTDeclared effective 333-2487199999999995-20-002652
2020-09-28S-1/AAmendment 333-2487190001193125-20-255106
2020-09-10S-1Registration filed 333-2487190001193125-20-243234
2020-08-06DRSDraft made public 377-033780000950123-20-007732

All filings of this company · CSV